Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2019. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
408651000001116 | Xylometazoline 70micrograms/dose / Ipratropium bromide 84micrograms/dose nasal spray | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
408661000001118 | Xylometazoline 70micrograms/dose / Ipratropium bromide 84micrograms/dose nasal spray (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Otrivine Extra Dual Relief 0.5mg/ml / 0.6mg/ml nasal spray (Haleon UK Ltd) | Is a | True | Xylometazoline 70micrograms/dose / Ipratropium bromide 84micrograms/dose nasal spray | Inferred relationship | Existential restriction modifier | |
Xylometazoline 70micrograms/dose / Ipratropium bromide 84micrograms/dose nasal spray 70 dose | Has VMP | True | Xylometazoline 70micrograms/dose / Ipratropium bromide 84micrograms/dose nasal spray | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets